Loading...
Loading...
Loading...

We are the Peptide Experts!

Tailored Peptide Synthesis for Every Application


Over the last 20 years, we have developed a unique and very broad expertise in peptide manufacturing and have pioneered patented technologies in the field of peptide libraries, pools and microarrays as well as micro-scale synthesis. 

Our offering ranges from micro-scale synthesis (10 - 50 nmol) to intermediate peptide synthesis (1 – 100 mg) with high throughput capacities for tens of thousands of peptides per month. Select your peptide format (pool, library, microarray...), peptide purity (from crude up to >98%) and optional modifications (phospho, biotin, dyes and labeld, cyclization, conjugation, stable-isotope labeling etc.).

Our state-of-the-art laboratories are located in Berlin, Germany and JPT operates according to the latest ISO 9001:2015 regulations.


Custom Peptide Synthesis


Our Quality Guarantee

Since 2004, JPT has maintained an active quality management system that is reviewed, audited and certified annually by an independent certification body (TÜV Rheinland) to ISO 9001 standards. This includes full process documentation and an early warning system in case of problems.



Product Finder

Filter by

Research Fields

Cell Therapy & Vaccines

Cell Therapy & Vaccines

JPT offers a large portfolio of peptide products and services supporting all development phases of new cell therapies and vaccines. These products range from discovery tools for epitope and target identification, to various peptide formats for immune monitoring and clinical grade peptides to support clinical vaccination and cell therapy trials.  Learn more
Immunology

Immunology

JPT has developed a variety of unique peptide-based products allowing systematic evaluation of cellular and humoral immunity. In addition to peptide formats allowing T-cell and B-cell epitope discovery, antigen-specific T-cell stimulation and immune monitoring our clinical grade products support clinical trials for the development of new immunotherapeutics and vaccines. Learn more
Neo-Epitope Discovery & Therapy

Neo-Epitope Discovery & Therapy

Neo-epitopes are important targets for individualized cancer immunotherapy. JPT’s high-throughput peptide techniques enable access to customized peptide products for neo-epitope prioritization and validation, individualized therapy development and immune monitoring. Learn more
Proteomics

Proteomics

Proteomics is the study of a cell's protein inventory at different times by protein identification and quantification. The application of mass spectrometry and more specifically LC-MS/MS has tremendously facilitated this process. JPT developed proprietary approaches for the provision of quantified custom peptides and ready-to-use products enabling protein biomarker identification and quantitation. Learn more
COVID-19

COVID-19

JPT was the first company responding to the Covid-19 pandemic with the launch of a broad SARS CoV-2 genome spanning portfolio of peptide tools. The ready to use and custom peptide tools include antigen spanning PepMixTM peptide pools and PepStarTM peptide microarrays of SARS-CoV-2 wild type and mutated antigen sequences as well as antigens from other relevant corona viruses.  Learn more
Loading...

News

Meet JPT’s New Managing Director – Aurélien Claeyssen

JPT Peptide Technologies has appointed Aurélien Claeyssen as managing director, effective January 1, 2024. We welcome the French expert in peptide manufacturing and research to our peptide family in Berlin. Let’s get to know him...
February 2024

Custom Peptide Modifications and what we do with them

We go the extra mile for your peptides! Our Specialties & Modifications include: 
  • Biotinylated and tagged peptides 
  • Fluorescent and FRET peptides
  • many more...
February 2024

Free ELISpot Workshop in Barcelona, Spain - Join us!


Are you eager to take your ELISpot know-how to the next level and talk to experts in the field? Sign up now!


February 2024

Check our list of products, click and go.

Get a quote